Product Surveillance, PostmarketingUnited States Food and Drug AdministrationDrug LabelingDrug ApprovalAdverse Drug Reaction Reporting SystemsNonprescription DrugsConsumer Product SafetyLegislation, DrugDrug-Related Side Effects and Adverse ReactionsClinical Trials, Phase IV as TopicDrug IndustryPopulation SurveillanceUnited StatesTherapeutic EquivalencyIntussusceptionAstringentsNasal DecongestantsDrug PackagingAntitussive AgentsSafetyDrugs, GenericPharmaceutical PreparationsSentinel SurveillanceDrug and Narcotic ControlVaccines, AttenuatedProduct LabelingEphedrineChemistry, PharmaceuticalInvestigational New Drug ApplicationDeodorantsDermatologic AgentsReye SyndromeJapanDrug MonitoringAntidiarrhealsAntirheumatic AgentsPhenylpropanolamineDrug ContaminationTechnology, PharmaceuticalRacepinephrineDosage FormsPruritus AniBiological ProductsDrug CompoundingPharmaceutical SolutionsTreatment OutcomeExcipientsPseudoephedrine